The Cooper Companies Price Target Raised to $180.00 at Stifel Nicolaus (COO)
Stifel Nicolaus upped their target price on shares of The Cooper Companies (NYSE:COO) from $150.00 to $180.00 in a research note issued on Friday. The firm currently has a “buy” rating on the stock. Stifel Nicolaus’ target price would suggest a potential upside of 11.50% from the stock’s previous close.
A number of other analysts have also recently weighed in on COO. Analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of The Cooper Companies in a research note on Tuesday, July 1st. They now have a $150.00 price target on the stock, down previously from $176.00. One analyst has rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to the company. The Cooper Companies currently has an average rating of “Hold” and a consensus price target of $144.00.
Shares of The Cooper Companies (NYSE:COO) opened at 160.47 on Friday. The Cooper Companies has a 1-year low of $116.95 and a 1-year high of $163.24. The stock’s 50-day moving average is $153.0 and its 200-day moving average is $136.3. The company has a market cap of $7.693 billion and a P/E ratio of 26.78.
The Cooper Companies (NYSE:COO) last posted its quarterly earnings results on Thursday, June 5th. The company reported $1.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.60 by $0.04. The company had revenue of $412.30 million for the quarter, compared to the consensus estimate of $411.41 million. During the same quarter in the previous year, the company posted $1.50 earnings per share. The company’s revenue for the quarter was up 7.4% on a year-over-year basis. On average, analysts predict that The Cooper Companies will post $6.88 earnings per share for the current fiscal year.
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units, CooperVision, Inc and CooperSurgical, Inc CooperVision is a global manufacturer providing products for contact lens wearers.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.